1 completed, 1 enrolling by invitation. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Oculo-Cognitive Addition Test (OCAT): new trials by email Literature Review of Oculo-Cognitive Addition Test (OCAT) trials Research Report on Oculo-Cognitive Addition Test (OCAT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments 24-hour Ambulatory Blood Pressure Monitoring, Oculo-Cognitive Addition Test (OCAT) - Narcolepsy, Idiopathic Hypersomnia | Enrolling by invitation | Mayo Clinic | 100 | 2022-05-18 | 2026-06-09 | |
| Non-intrusive Detection of Temporary Neurologic Impairment By Opioids Oxycodone, Placebo, EyeLink 1000 Plus - Healthy | Phase 1 / Phase 2 | Completed | Mayo Clinic | 14 | 2020-02-28 | 2023-04-05 |
Idiopathic Hypersomnia (1) · Narcolepsy (1)
Mayo Clinic (2)
United States (2)
Chad Ruoff, MD (1) · Gaurav Pradhan, PhD (1)